Literature DB >> 31443963

MiR-143-3p suppresses the progression of nasal squamous cell carcinoma by targeting Bcl-2 and IGF1R.

Yi Qian1, Yaoshu Teng2, Yuandong Li3, Xiaojiang Lin4, Ming Guan5, Yong Li5, Xiaolin Cao5, Yueqiu Gao5.   

Abstract

Dysregulated microRNAs (miRNAs) play crucial roles in the occurrence and development of multiple tumours, but their roles in the progression of nasal squamous cell carcinoma (NSCC) remain unknown. The aim of our study was to investigate the potential function and molecular mechanism of miR-143-3p in NSCC. Expression of miRNA and mRNA was detected by quantitative real-time reverse transcription-PCR (qRT-PCR). Forced overexpression of miR-143-3p was established by transfecting mimics into NSCC cell line. Then, we investigated the role of miR-143-3p in human NSCC cell proliferation, apoptosis, cycle and migration by using MTT, flow cytometry and transwell assays. Bioinformatics analysis, qRT-PCR, Western blot and luciferase reporter analysis were performed to validate the relationship between miR-143-3p and its potential targets. We found that miR-143-3p was substantially downregulated in human NSCC tissues and cell line. Forced upregulation of miR-143-3p significantly attenuated cell proliferation and migration. Furthermore, this change could induce apoptosis and G1-phase arrest of NSCC cells. Mechanistically, miR-143-3p directly targeted and significantly suppressed Bcl-2 and IGF1R expression. In summary, miR-143-3p regulation of the proliferation, apoptosis, cell cycle and migration of NSCC probably partly depends on inhibition of Bcl-2 and IGF1R, indicating that miR-143-3p may be a novel molecular therapeutic target for NSCC.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Nasal tumour; Target gene; miR-143-3p; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31443963     DOI: 10.1016/j.bbrc.2019.08.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  miR-143-3p Targets lncRNA PSMG3-AS1 to Inhibit the Proliferation of Hepatocellular Carcinoma Cells.

Authors:  Jianlin Zhang; Jin Huang; Weidong Chen; Zhiwan Hu; Xingyu Wang
Journal:  Cancer Manag Res       Date:  2020-07-27       Impact factor: 3.989

2.  Inhibition of microRNA-143-3p Attenuates Cerebral Ischemia/Reperfusion Injury by Targeting FSTL1.

Authors:  Shunda Wang; Zhenguo Liu
Journal:  Neuromolecular Med       Date:  2021-03-11       Impact factor: 3.843

3.  Long non‑coding RNA MCM3AP‑AS1 drives ovarian cancer progression via the microRNA‑143‑3p/TAK1 axis.

Authors:  Jihong Wen; Shumei Han; Man Cui; Yanli Wang
Journal:  Oncol Rep       Date:  2020-07-17       Impact factor: 3.906

4.  Exploration of the Effect on Genome-Wide DNA Methylation by miR-143 Knock-Out in Mice Liver.

Authors:  Xingping Chen; Junyi Luo; Jie Liu; Ting Chen; Jiajie Sun; Yongliang Zhang; Qianyun Xi
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 6.208

5.  Forced expression of miR-143 and -145 in cardiomyocytes induces cardiomyopathy with a reductive redox shift.

Authors:  Jun Ueda; Takehiro Ogata; Kota Ogawa; Akiko Noda; Rumiko Matsuyama; Yuji Nishizawa; Shanlou Qiao; Satoru Iwata; Morihiro Ito; Yoshitaka Fujihara; Masatoshi Ichihara; Koichi Adachi; Yuji Takaoka; Takashi Iwamoto
Journal:  Cell Mol Biol Lett       Date:  2020-08-24       Impact factor: 5.787

6.  Circulating skeletal muscle related microRNAs profile in Piedmontese cattle during different age.

Authors:  Rupal S Tewari; Ugo Ala; Paolo Accornero; Mario Baratta; Silvia Miretti
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.